AVIJF yields 2.02% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, AVIJF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AVIJF + MRK for your $10,000?
AviChina Industry & Technology Company Limited engages in the research, development, manufacture, and sale of civil aviation products and related engineering services. It operates through three segments: Aviation Entire Aircraft Business, Aviation Ancillary System and Related Business, and Aviation Engineering Services Business. The company is involved in the development, manufacture, sale, and upgradation of defense and civil aviation products, such as helicopters, trainer and general-purpose aircrafts, and regional jets; and manufacture and sale of aviation ancillary system products, including connectors, avionics products, and its accessories. It also offers component products, including optical and electrical interconnection components and assemblies, cable assemblies, system interconnection equipment, fluid devices and equipment, etc., that are used in aviation, aerospace and other military fields, communications and data transmission, and new energy vehicles, as well as rail civil high-end manufacturing fields, such as transportation, consumer electronics, industry, energy, medical care, and intelligent equipment. In addition, the company provides various aviation power supply systems, fire extinguishing systems, environmental control systems, engine ignition systems and accessories, etc. Further, it offers aviation engineering services, such as planning, design, consultation, construction services. The company was incorporated in 2003 and is based in Beijing, the People's Republic of China. AviChina Industry & Technology Company Limited is a subsidiary of Aviation Industry Corporation of China, Ltd.
Full AVIJF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.